Insilicos and GeneBio Sign Global Distribution Agreement
Geneva, Switzerland and Seattle, Washington, USA; 22 September 22 2006 - Geneva Bioinformatics (GeneBio) SA and Insilicos LLC today announced a partnership agreement that links GeneBio's Phenyx software platform for MS data analysis together with Insilicos' IPP (Insilicos Proteomics Pipeline), a high-performance proteomics pipeline, based on the TPP proteomics tools developed by Dr. Ruedi Aebersold's lab at the Institute for Systems Biology (ISB).
Under the terms of the agreement, Insilicos will be the exclusive global reseller of a bundled Phenyx/IPP offer, while GeneBio will be the exclusive European reseller of this Phenyx/IPP bundle. In addition, GeneBio and Insilicos have acquired the right to non-exclusively sell each other's products in Europe and North America, respectively. The technical aspect of the partnership involves the inclusion of Phenyx within the IPP, thereby allowing both IPP and TPP users to seamlessly utilize Phenyx within their specific workflows.
Phenyx is a software platform for the identification and characterization of proteins and peptides from mass spectrometry data specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic high quality results assessment. IPP is a high performance software system for the identification and analysis of proteomics data resulting from an open-source collaboration led by the ISB to further develop their TPP. IPP brings major advances in speed, usability and workflow efficiency to all users of TPP.
"We are delighted to have an opportunity to work with GeneBio and the Phenyx platform as it relates to our IPP," said Erik Nilsson, CEO of Insilicos. "We realize that Phenyx is a powerful alternative to existing MS search engines and we want to give customers the best solutions available when it comes to implementing their IPP systems. We believe Phenyx is a unique platform offering a variety of features not found in other search engines, which is why we want the opportunity to resell the platform in North America. We believe this is the beginning of a prosperous relationship."
"We believe that the IPP is an important step forward for users of TPP and we want to insure that our Phenyx platform can be utilized seamlessly within the IPP workflow," said Nasri Nahas, CEO of GeneBio. "Enabling IPP users to work closely with Phenyx will instantly expand the potential Phenyx user base, while at the same time allowing IPP users to experience the latest version of our powerful data analysis platform. We believe this TPP "booster" to be an important and welcomed enhancement and look forward to championing it throughout Europe. We are excited about the future possibilities of this relationship."
About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, we focus our expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community. For more information about GeneBio, please visit: www.genebio.com.
About Insilicos
Insilicos LLC is a biomarker discovery and diagnostic development company, concentrating on cardiovascular disease.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' 'PreClue," and 'Life Science Software' are trademarks of Insilicos LLC.
